Luca Grumolato

Dr. Luca Grumolato

1. Laboratoire Différenciation et Communication Neuronale et Neuroendocrine, UNIROUEN, INSERM, Normandie Université, 76183 Rouen, France
+1
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2010 in Genes & Development
Verified
Journal Article
Closed access
PDF file
LGLuca Grumolato
Luca Grumolato
GLGuizhong Liu
Guizhong Liu
PMPhyllus Mong
Phyllus Mong
RMRaksha Mudbhary
Raksha Mudbhary
RBRomi Biswas
Romi Biswas
SAStuart A. Aaronson
Stuart A. Aaronson
Wnt ligands signal through β-catenin and are critically involved in cell fate determination and stem/progenitor self-renewal. Wnts also signal through β-catenin-independent or noncanonical pathways that regulate crucial events during embryonic development. The mechanism of noncanonical receptor activation and how Wnts trigger canonical as opposed to noncanonical signaling have yet to be elucidated. We demonstrate here that prototype canonical Wnt3a and noncanonical Wnt5a ligands specifically trigger completely unrelated endogenous coreceptors—LRP5/6 and Ror1/2, respectively—through a common mechanism that involves their Wnt-dependent coupling to the Frizzled (Fzd) coreceptor and recruitment of shared components, including dishevelled (Dvl), axin, and glycogen synthase kinase 3 (GSK3). We identify Ror2 Ser 864 as a critical residue phosphorylated by GSK3 and required for noncanonical receptor activation by Wnt5a, analogous to the priming phosphorylation of low-density receptor-related protein 6 (LRP6) in response to Wnt3a. Furthermore, this mechanism is independent of Ror2 receptor Tyr kinase functions. Consistent with this model of Wnt receptor activation, we provide evidence that canonical and noncanonical Wnts exert reciprocal pathway inhibition at the cell surface by competition for Fzd binding. Thus, different Wnts, through their specific coupling and phosphorylation of unrelated coreceptors, activate completely distinct signaling pathways.

15 January 2008 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LGLuca Grumolato
Luca Grumolato
HGHafida Ghzili
Hafida Ghzili
MMMaité Montero‐Hadjadje
Maité Montero‐Hadjadje
SGStéphane Gasman
Stéphane Gasman
Jean LesageJean Lesage
Jean Lesage
YAYoussef Anouar
Youssef Anouar
Selenoproteins contain the essential trace element selenium, the deficiency of which is associated with cancer or accelerated aging. Although selenoproteins are thought to be instrumental for the effects of selenium, the biological function of many of these proteins remains unknown. Here, we studied the role of selenoprotein T (SelT), a selenocysteine (Sec) ‐containing protein with no known function, which we have identified as a novel target gene of the neuropeptide pituitary adenylate cyclase‐activating polypeptide (PACAP) during PC12 cell differentiation. SelT was found to be ubiquitously expressed throughout embryonic development and in adulthood in rat. Immunocytochemical analysis revealed that SelT is mainly localized to the endoplasmic reticulum through a hydrophobic domain. PACAP and cAMP induced a rapid and long‐lasting increase in SelT gene expression in PC12 cells, in a Ca 2+ ‐dependent manner. These results suggested a possible role of SelT in PACAP signaling during PC12 cell differentiation. Indeed, overexpression of SelT in PC12 cells provoked an increase in the concentration of intracellular Ca 2+ ([Ca 2+ ] i ) that was dependent on the Sec residue. Conversely, SelT gene knockdown inhibited the PACAP‐induced increase in [Ca 2+ ] i and reduced hormone secretion. These findings demonstrate the implication of a selenoprotein in the regulation of Ca 2+ homeostasis and neuroendocrine secretion in response to a cAMP‐stimulating trophic factor.— Grumolato, L., Ghzili, H., Montero‐Hadjadje, M., Gasman, S., Lesage, J., Tanguy, Y., Galas, L., Ait‐Ali, D., Leprince, J., Guerineau, N. C., Elkahloun, A. G., Fournier, A., Vieau, D., Vaudry, H., Anouar, Y. Selenoprotein T is a PACAP‐regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 22, 1756–1768 (2008)

6 April 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
GLGuizhong Liu
Guizhong Liu
SVSapna Vijayakumar
Sapna Vijayakumar
LGLuca Grumolato
Luca Grumolato
RARandy Arroyave
Randy Arroyave
HQHuiFang Qiao
HuiFang Qiao
SAStuart A. Aaronson
Stuart A. Aaronson
Genetic evidence indicates that Wnt signaling is critically involved in bone homeostasis. In this study, we investigated the functions of canonical Wnts on differentiation of adult multipotent human mesenchymal stem cells (hMSCs) in vitro and in vivo. We observe differential sensitivities of hMSCs to Wnt inhibition of osteogenesis versus adipogenesis, which favors osteoblastic commitment under binary in vitro differentiation conditions. Wnt inhibition of osteogenesis is associated with decreased expression of osteoblastic transcription factors and inhibition of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation, which are involved in osteogenic differentiation. An hMSC subpopulation exhibits high endogenous Wnt signaling, the inhibition of which enhances osteogenic and adipogenic differentiation in vitro. In an in vivo bone formation model, high levels of Wnt signaling inhibit de novo bone formation by hMSCs. However, hMSCs with exogenous expression of Wnt1 but not stabilized β-catenin markedly stimulate bone formation by naive hMSCs, arguing for an important role of a canonical Wnt gradient in hMSC osteogenesis in vivo.

1 May 2011 in Cancer Cell
Verified
Journal Article
Closed access
SVSapna Vijayakumar
Sapna Vijayakumar
GLGuizhong Liu
Guizhong Liu
IRIoana A. Rus
Ioana A. Rus
SYShen Yao
Shen Yao
YCYan Chen
Yan Chen
SAStuart A. Aaronson
Stuart A. Aaronson

13 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
HCHoussein Chhouri
Houssein Chhouri
DAdavid Alexandre
david Alexandre
LGLuca Grumolato
Luca Grumolato
Non-small cell lung cancers (NSCLC) harboring activating mutations of the epidermal growth factor receptor (EGFR) are treated with specific tyrosine kinase inhibitors (EGFR-TKIs) of this receptor, resulting in clinically responses that can generally last several months. Unfortunately, EGFR-targeted therapy also favors the emergence of drug tolerant or resistant cells, ultimately resulting in tumor relapse. Recently, cellular barcoding strategies have arisen as a powerful tool to investigate the clonal evolution of these subpopulations in response to anti-cancer drugs. In this review, we provide an overview of the currently available treatment options for NSCLC, focusing on EGFR targeted therapy, and discuss the common mechanisms of resistance to EGFR-TKIs. We also review the characteristics of drug-tolerant persister (DTP) cells and the mechanistic basis of drug tolerance in EGFR-mutant NSCLC. Lastly, we address how cellular barcoding can be applied to investigate the response and the behavior of DTP cells upon EGFR-TKI treatment.

1 August 2016 in Molecular Cell
Verified
Journal Article
Closed access
AGAlexis Guernet
Alexis Guernet
SMSathish-Kumar Mungamuri
Sathish-Kumar Mungamuri
DCDorthe Cartier
Dorthe Cartier
RSRavi Sachidanandam
Ravi Sachidanandam
AJAnitha Jayaprakash
Anitha Jayaprakash
LGLuca Grumolato
Luca Grumolato